Clinical and FDG-PET markers of immune checkpoint inhibitor (ICI) response in patients with metastatic Merkel cell carcinoma (mMCC) von Weppler, A.M., Bhave, P., De Ieso, P., Chua, M., Raleigh, J., Hatzimihalis, A., Gill, A., Balachander, S., Callahan, J., Pattison, A., Caneborg, A., Au Yeung, G., McArthur, G., Hicks, R.J., Tothill, R., Sandhu, S.K.

Volltext

32 Does faecal calprotectin measurement have an impact on patient management? von Callaghan, B, Lynch, P, Jacob, S, Caneborg, K, Love, K

Volltext

γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival von Gherardin, Nicholas A, Waldeck, Kelly, Caneborg, Alex, Martelotto, Luciano G, Balachander, Shiva, Zethoven, Magnus, Petrone, Pasquale M, Pattison, Andrew, Wilmott, James S, Quiñones-Parra, Sergio M, Rossello, Fernando, Posner, Atara, Wong, Annie, Weppler, Alison M, Shannon, Kerwin F, Hong, Angela, Ferguson, Peter M, Jakrot, Valerie, Raleigh, Jeanette, Hatzimihalis, Athena, Neeson, Paul J, Deleso, Paolo, Johnston, Meredith, Chua, Margaret, Becker, Juergen C, Sandhu, Shahneen, McArthur, Grant A, Gill, Anthony J, Scolyer, Richard A, Hicks, Rodney J, Godfrey, Dale I, Tothill, Richard W

Volltext